Mergers and Acquisitions
Subscribe to Mergers and Acquisitions

The Lead

Chinese consortium to jointly acquire U.S. biotechnology company Ambrx

May 22, 2015 9:42 am | by PRNewswire | News | Comments

A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright Limited's healthcare fund ("CEL Healthcare Fund"), and WuXi PharmaTech announced today that the Consortium ...

Tribute Pharmaceuticals announces expansion into U.S. market

May 21, 2015 4:21 pm | by Associated Press | News | Comments

Tribute Pharmaceuticals Canada Inc., a specialty pharmaceutical company with a primary focus on...

Achillion shares sink after partnering with Johnson & Johnson

May 21, 2015 11:56 am | by TOM MURPHY, AP Business Writer | News | Comments

Investors started shedding Achillion shares early Wednesday, less than a day after the drugmaker...

CVS to Acquire Drug Distributor Omnicare for $10.4 B

May 21, 2015 11:34 am | by TOM MURPHY, AP Business Writer | News | Comments

CVS Health will spend more than $10 billion to buy pharmacy services provider Omnicare and tap a...

View Sample

FREE Email Newsletter

Endo’s Purchase of Par Pharma Shakes up the Industry

May 21, 2015 11:03 am | News | Comments

US Pharma M&A activity has yet to show any signs of a slowdown after the $8.1bn exit of Par Pharma by TPG to Endo was announced on Monday. The US Pharma industry has seen 39 deals valued at US$ 77.3bn to-date, three more deals announced ...

Boehringer Makes Phase 1 Acquisition

May 18, 2015 1:21 pm | by Associated Press | News | Comments

Boehringer Ingelheim and pharmaceutical company Pharmaxis announce that Boehringer Ingelheim has exercised its option and acquired the investigational drug PXS4728A, to develop it for the treatment of the liver-related condition NASH and ...

Endo Buying Par Pharma In Generics Push

May 18, 2015 1:15 pm | by Associated Press | News | Comments

Endo International will spend about $8.05 billion to acquire Par Pharmaceutical as it pushes further into the generic drug market. Endo CEO Rajiv De Silva said the deal make Endo one of the top five generics companies as measured by U.S. sales.


FTC Seeks More Info From Pfizer About Hospira Acquisition

May 15, 2015 12:04 pm | by Pfizer Inc. | News | Comments

Pfizer Inc. today announced that it has received a request for additional information from the FTC with respect to its previously announced proposed acquisition of Hospira.

Eli Lilly, Sanford-Burnham Announce Collaboration

May 14, 2015 12:00 pm | by Eli Lilly and Company | News | Comments

Eli Lilly and Company and Sanford-Burnham Medical Research Institute today announced that they will collaborate to discover and develop immunological therapies.

ProPharma Group Acquires PROSAR

May 14, 2015 11:21 am | by ProPharma Group | News | Comments

ProPharma Group, a  compliance services company, today announced its acquisition of PROSAR, a provider of pharmacovigilance and medical information services.

Pfizer Acquires Minority Interest in AM-Pharma

May 12, 2015 11:41 am | by Pfizer | News | Comments

Pfizer recently announced their acquisition of a minority equity interest in AM-Pharma, and secured an exclusive option to acquire the remaining equity in the company.

Juno Acquires Stage Cell

May 12, 2015 11:15 am | by Juno Therapeutics | News | Comments

Juno Therapeutics, a biopharmaceutical company focused on cancer treatment, announced today that it has acquired Stage Cell Therapeutics GmbH.


Endo Acquires Portfolio of Branded and Generic Products

May 11, 2015 11:06 am | by Endo International | News | Comments

Endo International has acquired a broad portfolio of branded and generic injectable and established products focused on pain, anti-infectives, cardiovascular and other specialty therapeutics areas.

BASF Sells Part of Its Pharma Business

May 11, 2015 10:20 am | by Andy Szal, Digital Reporter | News | Comments

BASF recently announced plans to sell several prominent pharmaceutical ingredients to Siegfried Holding AG for $306 million.

Pharmaceuticals, Life Sciences Show Dramatic Jump in Merger Activity

May 8, 2015 11:15 am | by Andy Szal, Digital Reporter | News | Comments

The pharmaceuticals and life sciences sectors saw 35 mergers and acquisitions worth $166.3 billion in the first three months of 2015, a value that eclipsed transactions from all of 2014.

MorphoSys Acquires Lanthio Pharma

May 7, 2015 11:16 am | by MorphoSys AG | News | Comments

MorphoSys AG announced today that it has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V.

Alexion Pharma to Pay $8.4 Billion for Synageva BioPharma

May 6, 2015 11:14 am | by Tom Murphy, AP Business Writer | News | Comments

Alexion Pharmaceuticals will pay a huge premium to buy fellow rare disease treatment maker Synageva BioPharma in an $8.4-billion deal for a company with no products on the market.


PlasmaTech Acquires Abeona

May 6, 2015 11:08 am | News | Comments

PlasmaTech Biopharmaceuticals has acquired Abeona Therapeutics, a company engaged in the development and commercialization of therapies for patients with lysosomal storage diseases.

Juno and Fate Therapeutics to Conduct Joint T-Cell Research

May 6, 2015 11:02 am | by Fate Therapeutics | News | Comments

Juno Therapeutics and Fate Therapeutics announced a strategic collaboration to identify and utilize small molecules to modulate Juno's genetically-engineered T cell product for potentially treating cancer patients.

Portola Enters Opthalmic Partnership with Ora

May 5, 2015 11:55 am | by Portola Pharmaceuticals | News | Comments

Portola Pharmaceuticals today announced a collaboration with Ora, Inc. for the development of Portola's highly selective Syk inhibitor, PRT2761, in ophthalmic diseases.

Immune Pharmaceuticals and STC Biologics Announce Strategic Partnership

May 4, 2015 11:34 am | by Immune Pharmaceuticals | News | Comments

Immune Pharmaceuticals and STC Biologics are entering into a strategic partnership to accelerate the development of NanomAbs, a new generation of Antibody Nanoparticle Conjugates allowing the targeted delivery of chemo-therapeutics.

Mylan Raises Offer To Acquire Perrigo

April 29, 2015 11:08 am | by Mylan | News | Comments

Mylan N.V. today announced that it has increased its offer to acquire the issued and to be issued shares of Perrigo.

Moberg Pharma Acquires Balmex

April 27, 2015 11:27 am | by Moberg Pharma | News | Comments

Net sales of the brand is trending on an annual rate exceeding $4 million.

Mylan Board Unanimously Rejects Unsolicited Expression of Interest From Teva

April 27, 2015 11:07 am | by PRNewswire | News | Comments

After a comprehensive review, the Mylan board concluded the approach did not meet any of the key criteria that would cause Mylan to depart from the company's longstanding strategy.

Teva’s Potential $40 Billion Acquisition of Mylan Could Transform Generics Space

April 24, 2015 11:26 am | by GlobalData | News | Comments

Mylan made an unsolicited $28.9 billion offer to buy the Irish drugmaker last week, but Perrigo’s board of directors unanimously rejected the proposal, saying that the merger substantially undervalues the company and its future growth prospects.

Teva Offers to Buy Mylan in $40.1B Cash-And-Stock Deal

April 21, 2015 10:29 am | by The Associated Press | News | Comments

The potential combination would result in a powerhouse of a generic drug developer competing against rivals such as Sun Pharma.

Mylan Comments on Merger Speculation

April 20, 2015 10:36 am | by PRNewswire | News | Comments

Mylan Executive Chairman Robert J. Coury commented, "We note that there has been some media speculation with regard to a potential bid for Mylan by Teva and that this rumor has been circulating for some time."

Sartorius Stedim Biotech Acquires BioOutsource

April 17, 2015 12:10 pm | by Sartorius Stedim Biotech Group | News | Comments

Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.

CollabRx and Medytox Solutions Sign Definitive Merger Agreement

April 16, 2015 3:47 pm | by Globe Newswire | News | Comments

Medytox currently owns and operates several healthcare companies, including clinical testing laboratories, an electronic medical records provider, a laboratory information systems company and a medical billing company. CollabRx is a leading informatics company focused on the interpretation of complex molecular and genetic tests in cancer.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.